Research Information Only — Educational content, not medical advice. Lab interpretation and any treatment decision belong to your licensed physician. Ranges are educational references.
The Whole Idea
You are the equation, not a variable
Almost everything sold online skips the one step that actually decides your outcome: looking at you. Your blood work is where "you" stops being an abstraction. It shows the metabolic stress a mirror can't, the hormone decline behind the fatigue, the inflammation running quietly in the background, and the safety flags that change or stop a plan entirely. Without it, every compound choice is a guess dressed up as expertise.
"To a forum, you're a stranger and a click. Your labs are the proof that you're not — that this decision is about your body, not someone else's protocol."
The Panel
What a comprehensive baseline covers
A real baseline isn't one number — it's a picture across systems. These are the marker groups that matter, and the ones a thoughtful protocol reads before it recommends anything.
Metabolic
- HbA1c — 3-month average glucose
- Fasting insulin — earliest resistance signal
- Fasting glucose + HOMA-IR
Inflammation
- hs-CRP — systemic inflammation
- Homocysteine
- Uric acid
Hormones (men & women)
- Total & free testosterone, estradiol, SHBG, DHEA-S, LH/FSH
- Full thyroid — TSH, free T4/T3, antibodies
Growth & stress
- IGF-1 — the GH-axis marker
- Cortisol (AM, fasted)
Cardiovascular
- ApoB & Lp(a) — beyond standard cholesterol
- LDL, HDL, triglycerides
Safety & foundation
- Kidney & liver — eGFR, ALT/AST, GGT
- CBC, ferritin, iron studies
- Vitamin D, B12, magnesium; PSA (men)
The Differentiator
Normal isn't the same as optimal
Here's the distinction most people never hear. The "normal" range a lab prints was built to flag disease — it's wide, and it's the wrong target for someone trying to function at their best. A functional or optimal range is narrower, aimed at where markers sit in genuinely healthy people. You can be squarely "normal" and still be nowhere near optimal — and that gap is often exactly where a peptide earns its place.
| Marker | Standard "normal" | Optimal target | Why the gap matters |
|---|
| Fasting insulin | 2–25 µIU/mL | 2–8 µIU/mL | A "normal" 12 can be an early insulin-resistance signal years before glucose moves. |
| HbA1c | < 5.7% | 4.8–5.4% | The upper "normal" band is where metabolic drift hides. |
| IGF-1 | Wide, age-based | Upper third for age | Bottom-of-range IGF-1 can be "normal" yet reflect a real GH-axis decline. |
| hs-CRP | < 3.0 mg/L | < 1.0 mg/L | Low-grade inflammation sits in the "acceptable" zone and drives aging. |
| Vitamin D | > 30 ng/mL | 40–60 ng/mL | "Sufficient" on paper, suboptimal for function. |
This is the core of the methodReading for optimal, not just normal is what turns a lab report from a disease screen into a performance map. It's also why two people with identical "normal" labs can need completely different plans — the detail lives in the gap between normal and optimal.
Lab → Compound
How each marker points to a peptide
This is where blood work stops being trivia and becomes a decision. A specific lab result doesn't just inform — it changes which compound is even relevant. A few of the clearest examples:
| If the lab shows… | | It points toward… | Because |
|---|
| Low IGF-1 for age | → | CJC-1295 + Ipamorelin | The most direct GH-axis rationale — restore your own GH signaling. |
| Elevated fasting insulin / HOMA-IR | → | MOTS-c (± SS-31) | AMPK activation targets glucose uptake and insulin sensitivity. |
| HbA1c ≥ 6.5% (diabetes) | → | Semaglutide leads | A locked algorithm rule — the diabetes-indicated GLP-1. |
| Elevated hs-CRP | → | Thymosin Alpha-1 | Inflammation confirmed → the immune modulator anchors. |
| Elevated cortisol + poor sleep | → | Selank / DSIP | Address the stress and sleep drivers, not just symptoms. |
| Low testosterone (men) | → | Kisspeptin (upstream) | Restore the hormonal axis rather than override it. |
The pointNotice what's happening: the labs are
driving the compound selection, not decorating it. This is the entire reason a lab-guided protocol beats a forum stack — the stack ignores the one thing that should decide everything.
See how the full selection logic works →
Safety
The labs that stop a plan
Blood work doesn't only open doors — it closes them, which is the part that protects you. Some results should change or halt a protocol before it starts:
- Kidney and liver function. Impaired eGFR or elevated liver enzymes change what's safe and how it's monitored.
- PSA (men). A flag here matters before any growth-signaling compound is considered — and belongs with a physician.
- Very high IGF-1. The GH axis isn't a "more is better" dial; elevated IGF-1 has cancer associations, so the target is the upper half of range, not the maximum.
- Glucose on diabetes medications. Coordination matters to avoid dangerous lows.
- Anything pointing to undiagnosed disease. A lab is sometimes the first sign of a problem that needs treating, not optimizing.
And Then Again Later
Retest — because response is the real dose
The baseline is only half the value. The other half is retesting, because the true measure of a dose was never a number off a forum — it's how your body responded. Did IGF-1 actually move? Did insulin come down? Did inflammation settle? Follow-up labs are how you separate "this is working" from "I feel like it's working," and how a plan gets adjusted to you over time instead of frozen at a guess.
Test, don't guess — then test againBaseline to know where you're starting. Follow-up to know whether it's doing anything. That loop is what makes a protocol yours, and it's the single habit that most separates people who get real results from people who spend money and hope.
Common Questions
Blood work & peptides, answered
What tests do I actually need?
A comprehensive baseline: metabolic (HbA1c, fasting insulin, glucose), inflammation (hs-CRP, homocysteine), full hormones (testosterone, estradiol, thyroid, IGF-1, cortisol), a lipid panel with ApoB, plus kidney, liver, iron, vitamin D, and PSA for men. Which markers matter most depends on the compound you're considering — and your physician interprets them.
Why is IGF-1 such a big deal?
It's the main downstream marker of growth hormone, and the most direct lab reason to consider GH-axis peptides. A low IGF-1 for your age says there may be something real to address; a normal one says the rationale is weak. Testing it is how you avoid taking a GH peptide for no reason.
My labs came back "normal" — so I'm fine?
Maybe, maybe not. "Normal" ranges are built to catch disease and are wide. An optimal range is narrower — a fasting insulin of 12 is "normal" but above the optimal 2–8, an early insulin-resistance signal. Reading for optimal is where the useful information lives.
Can I just skip the labs?
You can, but then you're guessing — about whether a compound targets anything real, whether a safety marker rules it out, and whether it's working. Blood work is what turns a peptide from a gamble into a decision. It's the least glamorous step and the one that matters most.
About the Author
SD
Dr. Scott DelBoccio, DMD
Founding Author · PeptideReport.ai
Dr. DelBoccio is a clinician with thirty years of practice who built a hormone and regenerative-wellness practice around individual bloodwork — personalizing compounds to a person's chemistry rather than handing out protocols off a shelf. PeptideReport.ai is the clinician-authored, education-only reference the peptide space lacked. No products are sold on this site.
Full Disclaimer
This page is for educational and scientific purposes only and does not constitute medical advice, diagnosis, or treatment. Reference and optimal ranges are educational and vary by laboratory and individual; only your licensed physician can order, interpret, and act on your blood work in the context of your full history. Lab-to-compound relationships described here are educational rationale, not prescribing guidance, and the compounds discussed are largely research/investigational. PeptideReport.ai does not manufacture, sell, or endorse any preparation. Content addresses adults 21 and older. Evidence and regulatory status continue to evolve.